Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110 , for relapsed/refractory chronic lymphocytic leukemia

✍ Scribed by Brown, J. R.; Byrd, J. C.; Coutre, S. E.; Benson, D. M.; Flinn, I. W.; Wagner-Johnston, N. D.; Spurgeon, S. E.; Kahl, B. S.; Bello, C.; Webb, H. K.; Johnson, D. M.; Peterman, S.; Li, D.; Jahn, T. M.; Lannutti, B. J.; Ulrich, R. G.; Yu, A. S.; Miller, L. L.; Furman, R. R.

• Book ID: 121694187
• Publisher: American Society of Hematology
• Year: 2014
• Tongue: English
• Weight: 241 KB
• Volume: 123
• Category: Article
• ISSN: 0006-4971
• DOI: 10.1182/blood-2013-11-535047